The ScholarGPS website collects information through the use of "cookies" or similar technologies in order to function more efficiently and analyze use of the website. You are free to restrict or block cookies as further explained in our Cookies Policy, however depending on the selection of your settings, the full features/functionality of the website may no longer be available.
Decline
Share:
Daiichi Sankyo Company, Limited
Tokyo, Japan
Kabushiki-gaishalead=yes}} is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 2,305.4 billion in revenue in 2018. The company owns the American biotechnology company Plexxikon, the German biotechnology company U3 Pharma, and recently sold Ranbaxy Laboratories in India. Daiichi Sankyo Co., Ltd. is the producer of Benicar (Olmesartan), an angiotensin II receptor antagonist and top selling drug in the U.S. Global sales of Olmesartan in 2013 were 300.2 billion yen.
